The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
External validation of a Dutch predictive nomogram for complete response to T-VEC in an independent American patient cohort.
 
Emma H.A. Stahlie
No Relationships to Disclose
 
Michael Carr
No Relationships to Disclose
 
Jonathan S. Zager
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Honoraria - Amgen; Castle Biosciences; Merck; Pfizer; Sanofi/Regeneron; Sun Pharma
Consulting or Advisory Role - Amgen; Castle Biosciences; Delcath Systems; Philogen; Sanofi/Regeneron
Speakers' Bureau - Pfizer; Sun Pharma
Research Funding - Amgen (Inst); Castle Biosciences (Inst); Delcath Systems (Inst); Novartis (Inst); Philogen (Inst); Provectus (Inst)
Patents, Royalties, Other Intellectual Property - US Patent 10,583,246
Travel, Accommodations, Expenses - Amgen; Array BioPharma; Merck
 
Alexander Christopher Jonathan Van Akkooi
Consulting or Advisory Role - 4SC (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Merck/Pfizer (Inst); MSD Oncology (Inst); Novartis (Inst); Pierre Fabre (Inst); Sanofi (Inst); Sirius Medical (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck/Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis